Recommended in Pharmacy

  • Clinical Essentials from Lancet Haematol
  • no comment

Follicular lymphoma: phase 3 trial confirms viability of rituximab biosimilar

More than 9 in 10 patients responded in both treatment arms.

Read more
  • Clinical Essentials from Stroke
  • 1 comment

Stroke prevention in Afib: nonvitamin K antagonist oral anticoagulants have the edge

Read more
  • Clinical Essentials from Lancet Psychiatry
  • 1 comment

For first-episode psychosis, second-generation antipsychotics generally equivalent

Read more
  • Clinical Essentials from FDA
  • 1 comment
  • FULLTEXT

HCV: FDA greenlights triple-DAA salvage therapy

Read more
  • Clinical Essentials from J Clin Oncol
  • 1 comment
  • FULLTEXT

Advanced lymphoma: CAR T-cell therapy delivers 73% remission rate

Read more
  • Clinical Essentials from J Med Virol
  • 1 comment

HCV-3: dual-DAA regimens are best

Read more
  • Clinical Essentials from Front Pharmacol
  • 1 comment
  • FULLTEXT

First-line FL: R-bendamustine delivers rapid, high-level MRD clearance

Read more
  • Clinical Essentials from Gastroenterology
  • 1 comment

Nurse's Health Study: PPIs not tied to cognitive decline

Read more
  • Clinical Essentials from FDA
  • 1 comment
  • FULLTEXT

HCV: FDA greenlights Vosevi salvage therapy

Read more

Professional Essentials

  • US Professional News
  • FULLTEXT

Demand for primary care physicians is increasing their pay

Read more
  • US Professional News
  • FULLTEXT

New standardized form eases patient record requests

Read more
  • US Professional News
  • FULLTEXT

Former USC medical dean in drug scandal

Read more
  • US Professional News
  • FULLTEXT

Time to understand ACI

Read more
  • US Professional News
  • FULLTEXT

Industry payments affect patient perception

Read more
  • US Professional News
  • FULLTEXT

Offer patients a nuanced view of the future

Read more
View more

New in Pharmacy

  • Clinical Essentials from Onco Targets Ther
  • 1 comment
  • FULLTEXT

Advanced breast cancer: first-line bevacizumab best with taxane-based chemotherapy

Results of a meta-analysis should settle the debate over how to use bevacizumab.

Read more
  • Clinical Essentials from Ann Oncol
  • 1 comment

Blood test detects EGFR when genetic test isn’t possible

Genetic testing isn’t possible in up to 20% of patients.

Read more
Digestive Disease Vitals for July 2017
  • Vitals
  • 1 comment

Digestive Disease Vitals for July 2017

PPIs are linked to increased mortality risk | In pediatric eosinophilic esophagitis nonresponders, check for allergy | GERD may be a sign to look for sleep apnea.

Read more
Adductor canal nerve blockade equivalent to FNB blockade for pain control after ACL reconstruction | AOSSM
  • Conference Essentials
  • 1 comment

Adductor canal nerve blockade equivalent to FNB blockade for pain control after ACL reconstruction | AOSSM

Quadriceps muscle activation deficits were lower for the ACB group at all timepoints.

Read more
Autologous conditioned plasma is first-line option for plantar fasciitis | AOSSM
  • Conference Essentials
  • 1 comment

Autologous conditioned plasma is first-line option for plantar fasciitis | AOSSM

ACP may optimize healing environment for tissue regeneration and repair.

Read more
  • Clinical Essentials from BMJ
  • 1 comment
  • FULLTEXT

Antidepressants during pregnancy linked to increase in autism risk

Best designed study to date finds 50% increased risk but the absolute risk is small.

Read more
  • Clinical Essentials from Arthritis Res Ther
  • 1 comment
  • FULLTEXT

Obese axial spondyloarthritis patients less likely to respond to TNFis

Yet the drugs are often continued inappropriately.

Read more
  • Clinical Essentials from Urol Oncol
  • 1 comment

Antihypertensive use higher after partial vs radical nephrectomy

Hemodynamic parameters were comparable to radical nephrectomy.

Read more
  • Clinical Essentials from Lancet Oncol
  • 1 comment

Breast cancer: DFS similar with exemestane, sequential tamoxifen/exemestane

Results from a phase 3 TEAM trial.

Read more
  • Clinical Essentials from Ann Oncol
  • 1 comment
  • FULLTEXT

Refractory NSCLC: eribulin fails to top other treatments

Phase 3 study did not demonstrate superiority of eribulin over physician's choice.

Read more
  • Clinical Essentials from J Am Coll Surg
  • 1 comment

Colorectal surgery: full bowel prep reduces surgical site infections

Oral antibiotics plus mechanical bowel preparation reduces risk by 80%.

Read more
  • Clinical Essentials from J Psychopharmacol
  • 1 comment

Depression: desvenlafaxine modestly improves energy levels

Fatigue and lassitude commonly persist in patients even after other symptoms have responded to treatment.

Read more
  • Clinical Essentials from JAMA Dermatol
  • 1 comment

Are your patients with atopic dermatitis afraid to use topical corticosteroids?

Some atopic dermatitis patients are "phobic" about using topical corticosteroids.

Read more
Diabetes Vitals for July 2017
  • Vitals
  • 1 comment

Diabetes Vitals for July 2017

Care managers may improve obesity, diabetes outcomes | Clearing HCV is good for type 2 diabetes control | Ask your patients if they can afford their diabetes medications | Switch to degludec may help T2D patients battling hypoglycemia on insulin glargine.

Read more